CISN - Drug Development

You Are Here: Drug Development

Drug / Device Development

If you are reading this section as an e-Training course, please read the
e-Training Quiz Introduction first and then return here.

Overview

This content has been reviewed by the National Cancer Institute for accuracy and completeness.

Drug development begins with an idea and moves through the entire research process beginning with basic research, moving into translational (preclinical) studies, and finally resulting in a clinical trial. Then the drug must navigate through the regulatory process. This section provides a big picture snapshot about this process, including information about the economics and the various stakeholders.

In this section we will discuss:

Review of Bench-to-Bedside Research
Stages of Drug Development Discovery
The Regulatory Process
Economics of Drug Development
Stakeholders
Featured Stakeholders: Patient Advocacy Groups
CISN Summary of Drug Development Challenges

	Section Index

	What We Know About Cancer
	How Cancer is Studied
●	Drug Development
	New Treatments
	Research Advocacy

«Previous Page